In 1988, doctors commenced the use of umbilical cord blood stem cells to treat diseases that were previously treated with bone marrow transplantation. Today, cord blood stem cells are successfully being used to save many lives and are considered as a viable alternative to bone marrow and peripheral blood stem cells. These hematopoietic stem cells (HSCs) can develop into any of the three types of blood cells: red cells, white cells or platelets.
The most significant advantage of cord blood transplantation over bone marrow or peripheral blood stem cell transplantation is that Bone marrow transplantation requires a 6/6 match whereas cord Blood Transplantation can be done with a 4/6 match.
Self use not recommended due to genetic and hereditary disorders.